BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 6976047)

  • 1. [Lymphocyte surface markers during treatment of non-Hodgkin's lymphomas].
    Trepińska E; Burchardt K
    Z Gesamte Inn Med; 1981 Sep; 36(18):681-2. PubMed ID: 6976047
    [No Abstract]   [Full Text] [Related]  

  • 2. [Non-Hodgkin's lymphoma: correlation of cell surface marker phenotype with clinical features and prognosis].
    Okabe K; Toki H; Kimura Y; Fujii M; Kiura K; Moriwaki S
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2960-4. PubMed ID: 3490224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surface markers of the lymphoid cells in non-Hodgkin's lymphoma].
    Płuzańska A; Polkowska-Kulesza E; Robak T; Kuźmicka J; Mazurowa A; Szadowska A; Woźniak L
    Acta Haematol Pol; 1980; 11(1):31-9. PubMed ID: 6966115
    [No Abstract]   [Full Text] [Related]  

  • 4. The monitoring of lymphocyte subpopulations in non Hodgkin lymphoma patients during chemotherapy.
    Hołowiecki J; Japa J; Krawczyk-Kuliś M; Stella-Hołowiecka B; Rudzka E; Jarczok K; Kamińska H
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):837-43. PubMed ID: 312089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lymphocyte subpopulations in non-Hodgkin's lymphoma during cytostatic therapy].
    Schnabel I; Fricke HJ; Jansa U; Lehmann G
    Z Gesamte Inn Med; 1979 Dec; 34(23):704-8. PubMed ID: 317767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
    Pluzańska A
    Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
    [No Abstract]   [Full Text] [Related]  

  • 7. 'Double marker' lymphocytes in patients receiving tetracycline.
    Pudifin DJ; Duursma J; Formo R; Brain P
    Clin Exp Immunol; 1978 Oct; 34(1):143-4. PubMed ID: 312167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional markers: a new perspective on malignant lymphomas.
    Jaffe ES; Braylan RC; Nanba K; Frank MM; Berard CW
    Cancer Treat Rep; 1977 Sep; 61(6):953-62. PubMed ID: 302739
    [No Abstract]   [Full Text] [Related]  

  • 9. Study of human T and B lymphocytes with heterologous antisera. IV. Subpopulations in tonsil and adenoid cell suspensions.
    Brochier J; Samarut C; Bich-Thuy LT; Revillard JP
    Immunology; 1978 Nov; 35(5):827-35. PubMed ID: 309859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface membrane markers on bovine peripheral blood lymphocytes.
    Reeves JH; Renshaw HW
    Am J Vet Res; 1978 Jun; 39(6):917-23. PubMed ID: 307351
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical and prognostic significance of the T-B immunological classification of non-Hodgkin's lymphomas.
    Ogasawara H; Fujitani T; Mizojiri G; Hattori H
    Laryngoscope; 1981 Jan; 91(1):125-32. PubMed ID: 7005580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukemic phase of non-Hodgkin's lymphomas. Hematological features and prognostic significance.
    Morra E; Lazzarino M; Orlandi E; Pagnucco G; Brusamolino E; Castello A; Inverardi D; Bernasconi C
    Haematologica; 1984; 69(1):15-29. PubMed ID: 6428991
    [No Abstract]   [Full Text] [Related]  

  • 13. Human blood lymphocyte subpopulations from birth to eight years.
    Falcão RP
    Clin Exp Immunol; 1980 Jan; 39(1):203-7. PubMed ID: 6966987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical utility of lymphocyte surface markers combined with the Lukes-Collins histologic classification in adult lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ; Frizzera G; Kersey JH; Goldman AI
    N Engl J Med; 1979 Sep; 301(10):512-8. PubMed ID: 313510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A study of non-Hodgkin's lymphoma (author's transl)].
    Kotoo Y
    Fukuoka Igaku Zasshi; 1978 Feb; 69(2):73-82. PubMed ID: 306366
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mixed lymphocyte culture. Correlation with PPD skin tests in patients with no-Hodgkin's lymphomata (author's transl)].
    Sasiain MC; Ruibal Ares B; Suárez A; Bachmann AE
    Sangre (Barc); 1979; 24(4):424-30. PubMed ID: 158225
    [No Abstract]   [Full Text] [Related]  

  • 17. [Surface markers of T and B lymphocytes: II. Their investigation in 13 patients with untreated acute lymphoblastic leukaemia (ALL) (author's transl)].
    Tomić BL
    Lijec Vjesn; 1980 Dec; 102(12):689-93. PubMed ID: 7022076
    [No Abstract]   [Full Text] [Related]  

  • 18. Reappraisal of lymphocyte subpopulations in sarcoidosis: demonstration of a specific deficiency of L lymphocytes.
    Lobo PI; Suratt PM
    J Clin Lab Immunol; 1979 Feb; 1(4):289-92. PubMed ID: 315470
    [No Abstract]   [Full Text] [Related]  

  • 19. Surface markers of lymphocytes and immunoglobulin alterations in chronic lymphocytic leukemia (CLL).
    Aydar S; Oğüt A; Undük H; Gündüz M
    New Istanbul Contrib Clin Sci; 1978 Mar; 12(2):152-60. PubMed ID: 16302701
    [No Abstract]   [Full Text] [Related]  

  • 20. [The effect of therapy on the behavior of T and B-lymphocytes in patients with non-Hodgkin's lymphoma].
    Franke A; Spormann H; Mey U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):872-7. PubMed ID: 6176513
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.